Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

[1]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[2]  A. Turpie,et al.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. , 2007, Chest.

[3]  J. Heit,et al.  Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism , 2007, American journal of hematology.

[4]  A. Amin,et al.  Thromboprophylaxis rates in US medical centers: success or failure? , 2007, Journal of thrombosis and haemostasis : JTH.

[5]  G. Moneta.  Fatal pulmonary embolism in hospitalised patients: a necropsy review , 2007 .

[6]  A. Panju,et al.  Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. , 2007, Thrombosis research.

[7]  R. Dubois,et al.  Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  A. Nicolaides,et al.  Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence) , 2006 .

[9]  M Greaves,et al.  Guidelines on the use and monitoring of heparin , 2006, British journal of haematology.

[10]  M. Prins,et al.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial , 2006, BMJ : British Medical Journal.

[11]  A. Turpie,et al.  Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients , 2005, Thrombosis and Haemostasis.

[12]  Clifford W Colwell,et al.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[13]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[14]  G. Hankey,et al.  Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. , 2004, Haematologica.

[15]  M. D. de Gregorio,et al.  Use of venous thromboembolism prophylaxis for surgical patients: a multicentre analysis of practice in Spain. , 2001, The European journal of surgery = Acta chirurgica.

[16]  J. Heit,et al.  Prevention of venous thromboembolism. , 2001, Clinics in geriatric medicine.

[17]  A. Turpie,et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. , 1999, The New England journal of medicine.

[18]  P. Prandoni,et al.  The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. , 1997, Haematologica.

[19]  J. Heit,et al.  Prevention of venous thromboembolism. , 1995, Chest.

[20]  B. Lindblad,et al.  Incidence of venous thromboembolism verified by necropsy over 30 years. , 1991, BMJ.

[21]  J. Martin,et al.  Autopsy Proven Pulmonary Embolism in Hospital Patients: Are We Detecting Enough Deep Vein Thrombosis? , 1989, Journal of the Royal Society of Medicine.

[22]  V. Kakkar,et al.  PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN Reappraisal of Results of International Multicentre Trial , 1977, The Lancet.

[23]  PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN An International Multicentre Trial , 1975, The Lancet.